3//SEC Filing
Aberdare Management Company, LLC 3
Accession 0001209191-18-038832
CIK 0001645666other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:48 PM ET
Size
9.4 KB
Accession
0001209191-18-038832
Insider Transaction Report
Form 3
Aberdare Management Company, LLC
10% Owner
Holdings
Series A Convertible Preferred Stock
→ Common Stock (105,162 underlying)Series B Convertible Preferred Stock
→ Common Stock (31,481 underlying)
Footnotes (2)
- [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock is convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The members of Aberdare Management Company, LLC are Paul H. Klingenstein and Kathleen R. Bole.
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001744257
Filing Metadata
- Form type
- 3
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 5:48 PM ET
- Size
- 9.4 KB